(Q27851763)
Statements
1 reference
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study (English)
1 reference
1 June 2012
0 references
30
0 references
16
0 references
1989-95
0 references